Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 30, 2024 06:00 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research Society

ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024
May 13, 2024 09:00 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting

ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
May 09, 2024 18:30 ET | Source: ProSomnus Sleep Technologies, Inc.

Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices

Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
May 08, 2024 20:53 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus Sleep Technologies Takes Strategic Action to Position Company for Long-Term Success

ProSomnus Sleep Technologies Takes Strategic Action to Position Company for Long-Term Success
February 22, 2024 08:30 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea

ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
January 30, 2024 08:00 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA

ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
January 29, 2024 08:00 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices

ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices
January 08, 2024 08:00 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea

PLEASANTON, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, welcomes the adoption of...
December 21, 2023 08:30 ET | Source: Apnimed, Inc.

Apnimed Announces First Patient Dosed in SynAIRgy, the Second Phase 3 Clinical Study of AD109, a Potential Nighttime Oral Treatment for Obstructive Sleep Apnea

-- SynAIRgy Compares AD109 to Placebo Over 6 Months in People with OSA who Are Intolerant of or Refuse Positive Airway Pressure (PAP) Therapy, the Current Standard of Care -- Part of a two-study...
October 31, 2023 20:00 ET | Source: Apnimed, Inc.

Apnimed Announces Launch of Joint Venture with Shionogi to Develop Novel Pharmacologic Therapies for Obstructive Sleep Apnea and other Sleep Disorders

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep...